Subhashis Banerjee - Apr 8, 2025 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role: Chief Medical Officer
Signature: /s/ Neha Krishnamohan, Attorney-in-Fact
Stock symbol: ARTV
Transactions as of: Apr 8, 2025
Transactions value $: $0
Form type: 4
Date filed: 4/25/2025, 05:07 PM
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARTV	Common Stock	Award	$0	+50K		$0.00	50K	Apr 8, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARTV	Employee Stock Option (Right to Buy)	Award	$0	+80K		$0.00	80K	Apr 8, 2025	Common Stock	80K	$1.92	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.
F2	25% of the shares initially subject to the option will vest and become exercisable on April 8, 2026, and the balance of the shares subject to the option shall vest and become exercisable at a rate of 1/36th per month over the following 36 months.